RA Hayward - American Journal of Managed Care, 2007 - ajmc.com Last year, the National Committee for Quality Assurance (NCQA) approved 2 new
Health Plan Employer Data and Information Set (HEDIS) measures for people with
diabetes mellitus (DM): to achieve a glycosylated hemoglobin (A1C) level ... Cited by 39 - Related articles - View as HTML - BL Direct - All 4 versions
- ►ecmaj.ca K Josan, SR Majumdar, FA McAlister - Canadian Medical Association Journal, 2008 - Can Med Assoc Dyslipidemia is the most important modifiable risk factor for myocardial
infarction worldwide,1 and serum cholesterol levels are directly related to mor-
tality from coronary artery disease in all populations studied.2–4 Over ... Cited by 34 - Related articles - BL Direct - All 13 versions
RA Hayward - New England Journal of Medicine, 2007 - content.nejm.org In this issue of the Journal, Landon and colleagues report on a Herculean
undertaking — a study of quality-improvement interventions conducted at 44
community health centers. 1 This study showed a modest improvement in some ... Cited by 29 - Related articles - BL Direct - All 4 versions
- ►nih.gov WC Cromwell, JD Otvos, MJ Keyes, MJ Pencina … - Journal of clinical lipidology, 2007 - Elsevier The cholesterol content of low-density lipoprotein (LDL) particles is variable,
causing frequent discrepancies between concentrations of LDL cholesterol (LDL-C)
and LDL particle number (LDL-P). In managing patients at risk for ... Cited by 19 - Related articles - All 23 versions
- ►endojournals.org A Garg, V Simha - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc Recently, considerable progress has been made in understanding the genetic basis
of dyslipidemias and in studying the safety and efficacy of lipid-lowering drugs
for coronary heart disease (CHD) prevention. Novel loci have been ... Cited by 16 - Related articles - All 3 versions
JB Kostis - Cardiovascular Drugs and Therapy, 2007 - Springer Abstract Background Clinical management of two key modifiable risk factors for
cardiovascular disease (CVD), hypertension and dyslipidemia, has evolved
considerably over the past 40 years, in terms of the focus of therapy, ... Cited by 10 - Related articles - BL Direct - All 3 versions
GA Diamond, S Kaul - The American Journal of Cardiology, 2007 - Elsevier It has been proposed recently that asymptomatic adults undergo routine screening
for subclinical atherosclerosis using electron-beam computed tomography or
carotid ultrasound as the basis for the pharmacologic prevention of ... Cited by 9 - Related articles - All 10 versions
- ►nih.gov VM Montori, M Breslin, M Maleska, AJ … - PLoS Med, 2007 - apop.allenpress.com Evidence-based medicine requires that clinical decisions be consistent not only
with the best available research evidence, but with the values and preferences
of the informed patient [1]. To achieve this goal, clinicians and patients ... Cited by 10 - Related articles - All 5 versions
R Minhas - International Journal of Clinical Practice, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 5 - Related articles - BL Direct - All 4 versions
GA Nichols, S Nag, W Chan - American Heart Journal, 2007 - Elsevier Among new statin initiators, 85.4% of very-high-risk patients received
minimal-guideline therapy in 2005, compared with 65.3% (P < .0001) in 2003. Of
all new initiators, <1% received very aggressive therapy in either year ... Cited by 5 - Related articles - All 28 versions
